Review



ns21 supplement  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems ns21 supplement
    Ns21 Supplement, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 66 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ns21 supplement/product/R&D Systems
    Average 94 stars, based on 66 article reviews
    ns21 supplement - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    R&D Systems ns21 supplement
    Ns21 Supplement, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ns21 supplement/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    ns21 supplement - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    R&D Systems n 21 max
    N 21 Max, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n 21 max/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    n 21 max - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    R&D Systems n 21
    N 21, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n 21/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    n 21 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    R&D Systems n21 max insulin free
    N21 Max Insulin Free, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n21 max insulin free/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    n21 max insulin free - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    R&D Systems vitamin a
    Vitamin A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vitamin a/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    vitamin a - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    R&D Systems n21 max insulin free supplement
    <t>N21</t> promotes β-cell formation. ( A ) Cell segmentation of confocal images to identify negative, GFP + , mCHERRY + (arrowheads) and mCHERRY + /GFP + (arrow) individual cells. ( B – D ) Mean intensity per SC-islet ( B ), % of β-cells per islet ( C ) and distribution of SC-islets ( D ) (n = 8) after N21 treatment during S7. Dots in B, C correspond to individual SC-islets. ( E ) Changes in the expression of β-cell genes INS and SLC30A8 upon supplementation of S7 medium with N21 as compared to control conditions (CNTRL). Dots represent values from independent differentiation experiments. ( F ) DNA normalized insulin content of SC-islets differentiated under control (CNTRL) and N21 supplemented S7 conditions and determined following static GSIS assays. Dots represent values from independent differentiation experiments. ( G , H ) Snapshots from the perifusion live imaging of INS GCaMP6 SC-islets, differentiated in the presence of N21 during S7, at low glucose (3mM) and in response to 16.7 mM Glucose + 60 mM KCl ( G ). The % of cells responsive to 16.7 mM Glucose + 60 mM KCl in individual INS GCaMP6 SC-islets are shown for control CNTRL and the N21 INS GCaMP6 SC-islets. Different colors correspond to independent differentiation experiments and dots correspond to individual SC-islets. Statistical analyses were performed by the non-parametric Kruskal–Wallis test using the H1 (parent line) as the control for the comparison with p ≤ 0.05 (*), p ≤ 0.005 (**) and p ≤ 0.0005 (***). Horizontal lines on the graphs represent the mean ± SEM. Scale bars correspond to 50 μm.
    N21 Max Insulin Free Supplement, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/n21 max insulin free supplement/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    n21 max insulin free supplement - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    R&D Systems x n21 max insulin free supplement
    (A) Cell segmentation of confocal images to identify negative, GFP + , mCHERRY + (arrowheads) and mCHERRY + /GFP + (arrow) individual cells. (B-D) Mean intensity per SC-islet (B), % of β-cells per islet (C) and distribution of SC-islets (D) (n=8) after <t>N21</t> treatment during S7. Dots in B, C correspond to individual SC-islets. (E) Changes in the expression of β-cell genes INS and SLC30A8 upon supplementation of S7 medium with N21 as compared to control conditions (CNTRL). Dots represent values from independent differentiation experiments. (F) DNA normalized insulin content of SC-islets differentiated under control (CNTRL) and N21 supplemented S7 conditions and determined following static GSIS assays. Dots represent values from independent differentiation experiments. (G, H) Snapshots from the perifusion live imaging of INS GCaMP6 SC-islets, differentiated in the presence of N21 during S7, at low glucose (3mM) (E) and in response to 16.7 mM Glucose + 60 mM KCl (G). The % of cells responsive to 16.7 mM Glucose + 60 mM KCl in individual INS GCaMP6 SC-islets are shown for control CNTRL and the N21 INS GCaMP6 SC-islets. Individual rectangles correspond to independent differentiation experiments and dots correspond to individual SC-islets. Statistical analyses were performed by the non-parametric Kruskal-Wallis test using the H1 (parent line) as the control for the comparison with p ≤ 0.05 (*), p ≤ 0.005 (**) and p ≤ 0.0005 (***). Horizontal lines on the graphs represent the mean ± SEM. Scale bars correspond to 50 μm.
    X N21 Max Insulin Free Supplement, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/x n21 max insulin free supplement/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    x n21 max insulin free supplement - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    N21 promotes β-cell formation. ( A ) Cell segmentation of confocal images to identify negative, GFP + , mCHERRY + (arrowheads) and mCHERRY + /GFP + (arrow) individual cells. ( B – D ) Mean intensity per SC-islet ( B ), % of β-cells per islet ( C ) and distribution of SC-islets ( D ) (n = 8) after N21 treatment during S7. Dots in B, C correspond to individual SC-islets. ( E ) Changes in the expression of β-cell genes INS and SLC30A8 upon supplementation of S7 medium with N21 as compared to control conditions (CNTRL). Dots represent values from independent differentiation experiments. ( F ) DNA normalized insulin content of SC-islets differentiated under control (CNTRL) and N21 supplemented S7 conditions and determined following static GSIS assays. Dots represent values from independent differentiation experiments. ( G , H ) Snapshots from the perifusion live imaging of INS GCaMP6 SC-islets, differentiated in the presence of N21 during S7, at low glucose (3mM) and in response to 16.7 mM Glucose + 60 mM KCl ( G ). The % of cells responsive to 16.7 mM Glucose + 60 mM KCl in individual INS GCaMP6 SC-islets are shown for control CNTRL and the N21 INS GCaMP6 SC-islets. Different colors correspond to independent differentiation experiments and dots correspond to individual SC-islets. Statistical analyses were performed by the non-parametric Kruskal–Wallis test using the H1 (parent line) as the control for the comparison with p ≤ 0.05 (*), p ≤ 0.005 (**) and p ≤ 0.0005 (***). Horizontal lines on the graphs represent the mean ± SEM. Scale bars correspond to 50 μm.

    Journal: Scientific Reports

    Article Title: Generation and application of novel hES cell reporter lines for the differentiation and maturation of hPS cell-derived islet-like clusters

    doi: 10.1038/s41598-024-69645-4

    Figure Lengend Snippet: N21 promotes β-cell formation. ( A ) Cell segmentation of confocal images to identify negative, GFP + , mCHERRY + (arrowheads) and mCHERRY + /GFP + (arrow) individual cells. ( B – D ) Mean intensity per SC-islet ( B ), % of β-cells per islet ( C ) and distribution of SC-islets ( D ) (n = 8) after N21 treatment during S7. Dots in B, C correspond to individual SC-islets. ( E ) Changes in the expression of β-cell genes INS and SLC30A8 upon supplementation of S7 medium with N21 as compared to control conditions (CNTRL). Dots represent values from independent differentiation experiments. ( F ) DNA normalized insulin content of SC-islets differentiated under control (CNTRL) and N21 supplemented S7 conditions and determined following static GSIS assays. Dots represent values from independent differentiation experiments. ( G , H ) Snapshots from the perifusion live imaging of INS GCaMP6 SC-islets, differentiated in the presence of N21 during S7, at low glucose (3mM) and in response to 16.7 mM Glucose + 60 mM KCl ( G ). The % of cells responsive to 16.7 mM Glucose + 60 mM KCl in individual INS GCaMP6 SC-islets are shown for control CNTRL and the N21 INS GCaMP6 SC-islets. Different colors correspond to independent differentiation experiments and dots correspond to individual SC-islets. Statistical analyses were performed by the non-parametric Kruskal–Wallis test using the H1 (parent line) as the control for the comparison with p ≤ 0.05 (*), p ≤ 0.005 (**) and p ≤ 0.0005 (***). Horizontal lines on the graphs represent the mean ± SEM. Scale bars correspond to 50 μm.

    Article Snippet: S7 medium was modified by supplementing it with 1 × N21-MAX insulin-free supplement (R&D SYSTEMS, AR010) during S7 (S7D1–S7D14).

    Techniques: Expressing, Control, Imaging, Comparison

    (A) Cell segmentation of confocal images to identify negative, GFP + , mCHERRY + (arrowheads) and mCHERRY + /GFP + (arrow) individual cells. (B-D) Mean intensity per SC-islet (B), % of β-cells per islet (C) and distribution of SC-islets (D) (n=8) after N21 treatment during S7. Dots in B, C correspond to individual SC-islets. (E) Changes in the expression of β-cell genes INS and SLC30A8 upon supplementation of S7 medium with N21 as compared to control conditions (CNTRL). Dots represent values from independent differentiation experiments. (F) DNA normalized insulin content of SC-islets differentiated under control (CNTRL) and N21 supplemented S7 conditions and determined following static GSIS assays. Dots represent values from independent differentiation experiments. (G, H) Snapshots from the perifusion live imaging of INS GCaMP6 SC-islets, differentiated in the presence of N21 during S7, at low glucose (3mM) (E) and in response to 16.7 mM Glucose + 60 mM KCl (G). The % of cells responsive to 16.7 mM Glucose + 60 mM KCl in individual INS GCaMP6 SC-islets are shown for control CNTRL and the N21 INS GCaMP6 SC-islets. Individual rectangles correspond to independent differentiation experiments and dots correspond to individual SC-islets. Statistical analyses were performed by the non-parametric Kruskal-Wallis test using the H1 (parent line) as the control for the comparison with p ≤ 0.05 (*), p ≤ 0.005 (**) and p ≤ 0.0005 (***). Horizontal lines on the graphs represent the mean ± SEM. Scale bars correspond to 50 μm.

    Journal: bioRxiv

    Article Title: Generation and application of novel hES cell reporter lines for the differentiation and maturation of hPS cell-derived islet-like clusters

    doi: 10.1101/2024.07.15.603551

    Figure Lengend Snippet: (A) Cell segmentation of confocal images to identify negative, GFP + , mCHERRY + (arrowheads) and mCHERRY + /GFP + (arrow) individual cells. (B-D) Mean intensity per SC-islet (B), % of β-cells per islet (C) and distribution of SC-islets (D) (n=8) after N21 treatment during S7. Dots in B, C correspond to individual SC-islets. (E) Changes in the expression of β-cell genes INS and SLC30A8 upon supplementation of S7 medium with N21 as compared to control conditions (CNTRL). Dots represent values from independent differentiation experiments. (F) DNA normalized insulin content of SC-islets differentiated under control (CNTRL) and N21 supplemented S7 conditions and determined following static GSIS assays. Dots represent values from independent differentiation experiments. (G, H) Snapshots from the perifusion live imaging of INS GCaMP6 SC-islets, differentiated in the presence of N21 during S7, at low glucose (3mM) (E) and in response to 16.7 mM Glucose + 60 mM KCl (G). The % of cells responsive to 16.7 mM Glucose + 60 mM KCl in individual INS GCaMP6 SC-islets are shown for control CNTRL and the N21 INS GCaMP6 SC-islets. Individual rectangles correspond to independent differentiation experiments and dots correspond to individual SC-islets. Statistical analyses were performed by the non-parametric Kruskal-Wallis test using the H1 (parent line) as the control for the comparison with p ≤ 0.05 (*), p ≤ 0.005 (**) and p ≤ 0.0005 (***). Horizontal lines on the graphs represent the mean ± SEM. Scale bars correspond to 50 μm.

    Article Snippet: S7 medium was modified by supplementing it with 1 x N21-MAX insulin-free supplement (R&D SYSTEMS, AR010) during S7 (S7D1-S7D14).

    Techniques: Expressing, Control, Imaging, Comparison